Extended report
Frequency of triggering bacteria in patients with reactive
arthritis and undifferentiated oligoarthritis and the relative
importance of the tests used for diagnosis
C Fendlera b, S Laitkoc, H Sörensend, C Gripenberg-Lerchee, A Grohf, J Uksilag, K Granforse, J Brauna, J Siepera b
a Department of
Medicine, Rheumatology, Klinikum Benjamin Franklin, Free University,
Berlin, Germany, b Deutsches Rheuma- forschungszentrum, Berlin, c Rheumaklinik
Buch, Berlin, d Immanuel-
Krankenhaus, Berlin, e National Public Health Institute, Department in
Turku, Finland, f Department of Microbiology, Jena, Germany, g Department of Medical
Microbiology, University of Turku, Finland
Correspondence to: Professor J Sieper, Rheumatology, Department of Medicine, Benjamin Franklin Hospital, Hindenburgdamm 30, 12200 Berlin, Germany hjsieper{at}zedat.fu-berlin.de
Accepted for publication 17 August
2000
OBJECTIVE
Reactive
arthritis (ReA) triggered by Chlamydia
trachomatis or enteric bacteria such as yersinia, salmonella,
Campylobacter jejuni, or shigella is an
important differential diagnosis in patients presenting with the
clinical picture of an undifferentiated oligoarthritis (UOA). This
study was undertaken to evaluate the best diagnostic approach.
PATIENTS AND
METHODS
52 patients with ReA, defined by arthritis
and a symptomatic preceding infection of the gut or the urogenital
tract, and 74 patients with possible ReA, defined by oligoarthritis
without a preceding symptomatic infection and after exclusion of other diagnoses (UOA), were studied. The following diagnostic tests were
applied for the identification of the triggering bacterium: for
yersinia induced ReA
stool culture, enzyme immunoassay (EIA), and
Widal's agglutination test for detection of antibodies to yersinia;
for salmonella or campylobacter induced ReA
stool culture, EIA for the
detection of antibodies to salmonella and
Campylobacter jejuni; for infections with
shigella
stool culture; for infections with
Chlamydia trachomatis
culture of the
urogenital tract, microimmunofluorescence and immunoperoxidase
assay for the detection of antibodies to Chlamydia
trachomatis.
RESULTS
A causative
pathogen was identified in 29/52 (56%) of all patients with ReA. In 17 (52%) of the patients with enteric ReA one of the enteric bacteria was
identified: salmonella in 11/33 (33%) and yersinia in 6/33 (18%).
Chlamydia trachomatis was the causative
pathogen in 12/19 (63%) of the patients with urogenic ReA. In patients
with the clinical picture of UOA a specific triggering bacterium was
also identified in 35/74 (47%) patients: yersinia in 14/74 (19%),
salmonella in 9/74 (12%), and Chlamydia
trachomatis in 12/74 (16%).
CONCLUSIONS
Chlamydia
trachomatis, yersinia, and salmonella can be identified as the
causative pathogen in about 50% of patients with probable or possible
ReA if the appropriate tests are used.
© 2001 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Rawlins, M. L., Gerstner, C., Hill, H. R., Litwin, C. M.
(2005). Evaluation of a Western Blot Method for the Detection of Yersinia Antibodies: Evidence of Serological Cross-Reactivity between Yersinia Outer Membrane Proteins and Borrelia burgdorferi. CVI
12: 1269-1274
[Abstract] [Full Text]
eLetters:
Read all eLetters
- Testing
- P Stowell
- Ann Rheum Dis Online, 29 May 2001 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
